Pfizer has announced plans to close six of its 20 research sites around the world.

Under the perhaps slightly disingenuous headline “Pfizer Announces Global Research Network”, the pharma company has come clean on what its recent merger with Wyeth will mean for its scientists.

In a statement, Pfizer said it would “significantly reduce R&D activities” at a number of sites, reducing its overall square footage of R&D by 35% and reducing 20 sites down to five main sites and nine specialized units (AP has the most user friendly breakdown of who is for the chop).

Pfizer has also admitted that there will be job losses, although it has not said how many researchers will be let go. The company has previously said it would reduce its total workforce by around 15% (approximately 20,000 people) after the merger.